Breaking old habits: Moving away from commonly used buffers in pharmaceuticals

European Pharmaceutical Review

Volumn 17, Issue 3, 2012, Pages

  Sek, David ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ASPARTIC ACID; BUFFER; CITRIC ACID; EXCIPIENT; FUMARIC ACID; HISTIDINE; LACTIC ACID; MALIC ACID; PHOSPHORIC ACID; SODIUM DIHYDROGEN PHOSPHATE; SUCCINIC ACID; TROMETAMOL;

ARTICLE; DRUG FORMULATION; DRUG INDUSTRY; DRUG SOLUBILITY; DRUG STABILITY; FOOD AND DRUG ADMINISTRATION; HYDROGEN BOND; PH;

EID: 84877000615     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (42)

1. Osterberg, R. E., Demerlis, C. C, Hobson, D. W., Mcgovern, T. J. (2011) Trends in Excipient Safety Evaluation. Int. J. Tox. 30, 600-610
2. FDA (2005) Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients
3. Jorgensen, L, Hostrup, S., Moeller, E. H., Grohganz H. (2009) Recent Trends in Stabilising Peptides and Proteins in Pharmaceutical Formulation - Considerations in the Choice of Excipients. Expert Opinion. 6, 1219-1230
4. Kamerzell, T. J., Esfandiary, R, Joshi, S. B., Middaugh, C. R, Volkin, D. B. (2011) Protein-Excipient Interactions: Mechanisms and Biophysical Characterization Applied to Protein Formulation Development. Adv. Drug Delivery Reviews. 63, 1118-1159
5. Stoll, V. S., Blanchard, J. S. (1990) Buffers: Principles and Practice. Methods in Enzymology. 182, 24-38
6. Trevino, S. R., Scholtz, J. M., Pace, C. N. (2008) Measuring and Increasing Protein Solubility. J. Pharm. Sci. 97, 4155-4166
7. Wang, W., Nema, S., Teagarden, D. (2010) Protein Aggregation-Pathways and Influencing Factors. Int. J. Pharmaceutics. 390, 89-99
8. Williams-Smith, D. (1977) Changes in Apparent pH on Freezing Aqueous Buffer Solutions and their Relevance to Biochemical Electron-Paramagnetic- Resonance Spectroscopy. Biochem. J. 167, 593-600.
9. Kolhe, P., Amend, E., Singh, S. K. (2010) Impact of Freezing on pH of Buffered Solutions and Consequences for Monoclonal Antibody Aggregation. Biotechnol. Prog. 26, 727-733
10. Gomez, G., Pikal, M. J., Rodriguez-Homedo, N. (2001) Effect of Initial Buffer Composition on pH Changes during Far-From-Equilibrium Freezing of Sodium Phosphate Buffer Solutions. Pharm. Res. 18, 90-97
11. Hatley R.H.M., Franks, F. (1989) The Cold-Induced Denaturation of Lactate Dehydrogenase at Sub-Zero Temperatures in the Absence of Perturbants. FEBS Lett 257,171-173
12. Almarsson, O., Seburg, R.A., Godshall, D., Tsai, E. W., Kaufman, M. J. (2000), Solid-State Chemistry of a Novel Carbapenem with a Releasable Sidechain, Tetrahedron 56, 6877-6885
13. Lam, X M., Costantino, H. R, Overcashier, D. E., Nguyen, T. H., and Hsu, C. C. (1996) Replacing Succinate with Glycolate Buffer Improves the Stability of Lyophilized Interferongamma. Int. J. Pharm. 142, 85-95
14. Bell, L.N., Labuza, T.P. (1991) Aspartame Degradation Kinetics as Affected by pH in Intermediate and Low Moisture Food Systems, J. Food Sci. 56, 17-20
15. Sarciaux, J.M., Mansour, S., Hageman, M.J., Nail, S.L. (1999) Effects of Buffer Composition and Processing Conditions on Aggregation of Bovine IgG during Freeze-Drying, J. Pharm. Sci. 88, 1354-1361
16. Pikal-Cleland, K.A., Carpenter, J.F. (2001) Lyophilization- Induced Protein Denaturation in Phosphate Buffer Systems: Monomelic and Tetrameric b-galactosidase, J. Pharm. Sci. 90, 1255-1268
17. Shalaev, E.Y., Gatlin, L.A. (2010) The Impact of Buffer on Solid-State Properties and Stability of Freeze-Dried Dosage Forms, in Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals (eds F. Jameel and S. Hershenson), John Wiley & Sons, Inc., Hoboken, NJ, USA
18. Laursen, T., Hansen, B., Fisker, S. (2006) Pain Perception After Subcutaneous Injections of Media Containing Different Buffers. Basic & Clinical Pharmacology & Toxicology. 98, 218-221
19. Veys, N., Dhondt, A., Lameire, N., (1998) Pain at the Injection Site of Subcutaneously Administered Erythropoietin: Phosphate-Buffered Epoetin Alpha Compared to Citrate-Buffered Epoetin Alpha and Epoetin Beta. Clin. Nephrol. 49, 41-44
20. Yu, A. W., Leung, C. B., Li, P. K., Lui, S. F., Lai, K. N. (1998) Pain Perception Following Subcutaneous Injections of Citrate-Buffered and Phosphate-Buffered Epoetin Alpha. Int. J. Artif. Organs. 21, 341-343
21. Arakawa, T., Philo, J.S., Kita, Y. (2001) Kinetic and Thermodynamic Analysis of Thermal Unfolding of Recombinant Erythropoietin. Biosci. Biotechnol. Biochem. 65, 1321-1327
22. Zhu, L, Zhang, XJ., Wang, L. Y., Zhou, J. M., Perrett, S. (2003) Relationship between Stability of Folding Intermediates and Amyloid Formation for the Yeast Prion Ure2p: A Quantitative Analysis of the Effects of pH and Buffer System. J. Mol. Biol. 328, 235-254
23. Arakawa, T. Tsumoto, K., Kita, Y., Chang, B., Ejima D. (2007) Biotechnology Applications of Amino Acids in Protein Purification and Formulations. Amino Acids. 33, 587-605
24. Chen, B., Bautista, R, Yu, K., Zapata, G. A., Mulkerrin, M. G., Chamow, S. M. (2003) Influence of Histidine on the Stability and Physical Properties of a Fully Human Antibody in Aqueous and Solid Forms. Pharmacol. Res. 20, 1952-1960
25. Tian, F., Middaugh, C. R, Offerdahl, T., Munsona, E., Sane, S., Rytting, J. H. (2007) Spectroscopic Evaluation of the Stabilization of Humanized Monoclonal Antibodies in Amino Acid Formulations. Int. J. Pharmaceutics. 335, 20-31
26. Katayama, D. S., Nayar, R, Chou, D. K., Valente, J. J., Cooper, J., Henry, C. S., VanderVelde, D. G., Villarete, L., Liu, C. P., Manning, M.C. (2006) Effect of Buffer Species on the Thermally Induced Aggregation of Interferon-Tau. J. Pharm. Sci. 95, 1212-1226
27. Wade, A. M., Tucker, H.N. (1998) Antioxidant Characteristics of L-Histidine. J. Nutr. Biochem. 9, 308-315
28. Thomas, D., Jaeger, U., Sagoschen, I., Lamberti, C, Wilhelm, K. (2009) Intra-Arterial Calcium Gluconate Treatment after Hydrofluoric Acid Bum of the Hand. Cardiovasc. Intervent. Radiol. 32, 155-158
29. Zheng, J. Y., Janis, L. J., (2006) Influence of pH, Buffer Species, and Storage Temperature on Physicochemical Stability of a Humanized Monoclonal Antibody LA298. Int. J. Pharmaceutics. 308, 46 51
30. Izutsu, K. I., Kadoya, S., Yomota, C, Kawanishi, T, Yonemochi, E., Terada, K. (2009) Freeze-Drying of Proteins in Glass Solids Formed by Basic Amino Acids and Dicarboxylic Acids. Chem. Pharm. Bull. 57, 43-48
31. Izutsu, K. I., Kadoya, S., Yomota, C, Kawanishi, T, Yonemochi, E., Terada, K. (2009) Stabilization of Protein Structure in Freeze-Dried Amorphous Organic Acid Buffer Salts. Chem. Pharm. Bull. 57, 1231-1236
32. B. Braun Medical Inc. TROPHAMINE - isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, cysteine hydrochloride, histidine, tyrosine, n-acetyl-tyrosine, alanine, arginine, proline, serine, glycine, aspartic acid, glutamic acid and taurine solution
33. GolovanovA.P., Hautbergue G.M., Wilson S.A., Lian L.Y. (2004) Simple Method for Improving Protein Solubility and Long-Term Stability. J. Am. Chem. Soc. 126, 8933-8939
34. Zhang M.Z., Wen J., Arakawa T., Prestrelski S.J. (1995) A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor. Pharmacol. Res. 12, 1447-1452
35. Zhang M.Z., Pikal K., Nguyen T, Arakawa T, Prestrelski S.J. (1996) The Effect of the Reconstitution Medium on Aggregation of Lyophilized Recombinant lnterieukin-2 and Ribonuclease A. Pharmacol. Res. 13: 643-646
36. Quinn, R, Andrade, J. D. (1983) Minimizing the Aggregation of Neutral Insulin Solutions. J. Pharm. Sci. 72, 1472-1473
37. Bringer, J., Heldt, A., Grodsky, G.M. (1981) Prevention of Insulin Aggregation by Dicarboxylic Amino Acids during Prolonged Infusion. Diabetes, 30, 83-85
38. Saso, L., Valentini, G., Casini, M.L., Matti, E., Braghiroli, L., Mazzanti, G., Panzironi, C, Grippa, E., Silvestrini, B. (1999) Inhibition of Protein Denaturation by Fatty Acids, Bile Salts and Other Natural Substances: A New Hypothesis for the Mechanism of Action of Fish Oil in Rheumatic Diseases. Jpn. J. Pharmacol.79, 89-99
39. Piedmonte, D. M., Treuheit, M. J. (2008) Formulation of Neulasta (pegflgrastim). Adv. Drug Delivery Reviews. 60, 50-58
40. Esue, O., Kanai, S., Liu, J., Patapoff, T. W. Shire, S. J., (2009) Carboxylate-Dependent Gelation of a Monoclonal Antibody. Pharm. Res. 26, 2478-2485
41. Sundaramurthi, P., Suryanarayanan, R., (2011) Predicting the Crystallization Propensity of Carboxylic Acid Buffers in Frozen Systems - Relevance to Freeze- Drying. J. Pharm. Sci. 100, 1288-1293
42. Sundaramurthi, P., Suryanarayanan, R., (2011) Thermophysical Properties of Carboxylic and Amino Acid Buffers at Subzero Temperatures: Relevance to Frozen State Stabilization. J. Phys. Chem. B. 115, 7154-7164